NERVOUS SYSTEM DAMAGE FOR COVID INFECTION IN ADOLESCENT. CLINICAL CASE
DOI:
https://doi.org/10.54890/.v1i1.231Abstract
Summary. The novel coronavirus infection COVID-19 in children in most cases is milder
than in adult patients, however, in combination with other acute infectious diseases,
background pathology and impaired immune reactivity, it can pose a particular threat.
According to the literature, the incidence of COVID-19 in children is 1–11%. Neurological
disorders in COVID-19 may be due to the “cytokine storm”, hypoxemia, neurotropism and
neurovirulence of SARS-CoV-2. An analysis of numerous publications on the new
coronavirus infection using the PubMed, Scopus, and Google Scholar databases indicates that
the meninges, vessels, and brain parenchyma may be involved in the pathological process.
This determines the need for a multidisciplinary approach to the treatment of COVID-19 and
its complications in children. The article describes a clinical case of severe COVID-19 caused
by SARS-CoV-2 with damage to the nervous system in a teenager.
Keywords:
adolescent, encephalitis, coronavirus infection COVID-19, SARS-CoV-2, pneumonia.References
1. Иванова Г.П. Лейкоэнцефалиты у детей: дифференциально-диагностические, патогенетические и терапевтические аспекты. [Автореф. дис. докт. мед. наук]. СПб.;2012.44 с.
2. Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):14. https://doi.org/ 10.3390/v12010014.
3. Das G, Mukherjee N, Ghosh S. Neurological insights of COVID-19 pandemic. ACS Chem Neurosci. 2020;11(9):1206–1209. https://doi.org/1021/acschemneuro.0c00201.
4. Dixon L, Varley J, Gontsarova A, Mallon D, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5):e789. https://doi.org/10.1212/ NXI.0000000000000789
5. Cardona GC, Quintana Pájaro LD, Quintero Marzola GC, et al. Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci. 2020; 412:116824. https://doi.org/10.1016/j.jns.2020.116824.
6. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatrics 2020. https://doi.org/1001/jamapediatrics.2020.1948
7. Временные методические рекомендации МЗ РФ «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)» Версия 7 (03.06.2020)
8. Brodin P. Why is COVID-19 so mild in children? Acta Paediatrica. 2020; 109(6):1082-1083. https://doi.org/10.1111/apa.15271
9. Lu X, Zhang L, Du H, Zhang J, Li J, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2005073
10. Cao Q. et al. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. Journal of the Formosan Medical Association. 2020; 119(3):670. https://doi.org/10.1016/j.jfma.2020.02.009
11. Dong Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020. https://doi.org/10.1542/peds.2020-0702
12. Xia W. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatric Рulmonology. 2020; 55(5):1169—1174. https://doi.org/10.1002/ppul.24718
13. Carlotti AP. COVID-19 Diagnostic and Management Protocol for Pediatric Patients. Clinics. 2020; 75. http://dx.doi.org/10.6061/clinics/2020/e1894
14. Hong H. et al. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatrics & Neonatology. 2020. http://doi.org/10.1016/j.pedneo.2020.03.001
15. Wei M. et al. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020; 323(13):1313—1314. http://doi.org/10.1001/jama.2020.2131
16. Cai J. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clinical Infectious Diseases. 2020. https://doi.org/10.1093/cid/ciaa198
17. CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12 March 16, 2020. MMWRMorb. Mortal. WklyRep. 2020; 69:343—346.
18. Горелов А.В. Новая коронавирусная инфекция COVID-19: особенности течения у детей в Российской Федерации. Педиатрия. 2020; 99(6):57—62.
Downloads
Published
How to Cite
Issue
Section
